WASHINGTON, Nov. 23, 2021 /PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S.
Mr. Goodson’s work at MCRA focuses primarily on international regulatory across various device types in orthopedics, spine, cardiovascular, neurology, wound care, and dental.
At MCRA, Dr. Saha provides guidance on regulatory strategy and submission development with a focus on neurological and physical medicine devices.
Robert joined MCRA on August 2, 2021 as Director, Neurointerventional Regulatory Affairs. At MCRA, Robert provides guidance on regulatory strategies and submission development for MCRA’s neurology clients. His work includes 510(k), Pre-Submissions, Investigational Device Exemptions (IDE), and Premarket Approvals (PMA).
MCRA's world class know-how and execution unlocks barriers, advancing our clients mission to better the availability of quality medical care to patients around the world.